Component
Curcumin plus piperine regimen
Curcumin plus piperine regimen. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Endoxifen AUC fell 12.4% with curcumin plus piperine, p=0.02.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/curcumin-research/30909366.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "43a5c2635c9fef8a31967689115b6152e81cf7d4d0f1687ffae113684c89d527", "start_char": 0, "end_char": 1407, "text_sha256": "43a5c2635c9fef8a31967689115b6152e81cf7d4d0f1687ffae113684c89d527"}
- experimental_model
- Within-patient pharmacokinetic comparison in tamoxifen-treated breast cancer patients
- exposure
- Tamoxifen 20-30 mg/day; curcumin 1200 mg three times/day, with or without piperine 10 mg three times/day
- limitations
- Small pharmacokinetic study, not a cancer recurrence trial. Piperine has independent effects; a particular CYP mechanism was not established.
- nutrient_topic
- Curcumin research collection; topical membership is not evidence of a direct dietary effect. · Curcumin
- organism
- Homo sapiens
- plain_language
- The combination reduced exposure to tamoxifen's active metabolite.
- primary_references
- [curcumin-p30909366] Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. (2019). https://pubmed.ncbi.nlm.nih.gov/30909366/ DOI: 10.3390/cancers11030403
- tissue_or_cell_type
- Plasma drug and metabolite AUC
Curcumin: metabolism, signaling and nutrient connections (2026-09-17) · lines 970–981
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Within-patient pharmacokinetic comparison in tamoxifen-treated breast cancer patients · source_derived_draft · unverified_draft
### curcumin-endoxifen-combination Endoxifen AUC fell 12.4% with curcumin plus piperine, p=0.02. Condition category: normal nutrient_topic: Curcumin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The combination reduced exposure to tamoxifen's active metabolite. organism: Homo sapiens tissue_or_cell_type: Plasma drug and metabolite AUC experimental_model: Within-patient pharmacokinetic comparison in tamoxifen-treated breast cancer patients limitations: Small pharmacokinetic study, not a cancer recurrence trial. Piperine has independent effects; a particular CYP mechanism was not established. exposure: Tamoxifen 20-30 mg/day; curcumin 1200 mg three times/day, with or without piperine 10 mg three times/day evidence_span: {"source_cache": "artifacts/curcumin-research/30909366.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "43a5c2635c9fef8a31967689115b6152e81cf7d4d0f1687ffae113684c89d527", "start_char": 0, "end_char": 1407, "text_sha256": "43a5c2635c9fef8a31967689115b6152e81cf7d4d0f1687ffae113684c89d527"} [curcumin-p30909366] Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. (2019). https://pubmed.ncbi.nlm.nih.gov/30909366/ DOI: 10.3390/cancers11030403
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.